ETRAVIRINE is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Carnegie Pharmaceuticals Llc. The primary component is Etravirine.
| Product ID | 80005-113_2048d81e-fa48-452e-a877-98414b1dbbd2 |
| NDC | 80005-113 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ETRAVIRINE |
| Generic Name | Etravirine |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-06-07 |
| Marketing Category | ANDA / |
| Application Number | ANDA215402 |
| Labeler Name | Carnegie Pharmaceuticals LLC |
| Substance Name | ETRAVIRINE |
| Active Ingredient Strength | 200 mg/1 |
| Pharm Classes | Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-06-07 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 42291-473 | etravirine | etravirine |
| 42291-474 | etravirine | etravirine |
| 60219-1720 | etravirine | etravirine |
| 60219-1721 | etravirine | etravirine |
| 60219-1722 | etravirine | etravirine |
| 69238-1720 | etravirine | etravirine |
| 69238-1721 | etravirine | etravirine |
| 69238-1722 | etravirine | etravirine |
| 69315-285 | ETRAVIRINE | ETRAVIRINE |
| 69315-286 | ETRAVIRINE | ETRAVIRINE |
| 80005-112 | ETRAVIRINE | ETRAVIRINE |
| 80005-113 | ETRAVIRINE | ETRAVIRINE |
| 53808-0787 | Intelence | Etravirine |
| 59676-570 | Intelence | etravirine |
| 59676-571 | Intelence | etravirine |
| 59676-572 | Intelence | etravirine |